Campania
In Campania region 41,8% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 208 cases of cervicocarcinoma and 84 related deaths and thus results to be c...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SEEd Medical Publishers
2008-09-01
|
| Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
| Subjects: | |
| Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1014 |
| _version_ | 1818027074998239232 |
|---|---|
| author | Maria Caterina Cavallo Filippo Cipriani Simone Gerzeli Nadia Demarteau Alessia Marocco Francesco Bamfi |
| author_facet | Maria Caterina Cavallo Filippo Cipriani Simone Gerzeli Nadia Demarteau Alessia Marocco Francesco Bamfi |
| author_sort | Maria Caterina Cavallo |
| collection | DOAJ |
| description | In Campania region 41,8% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 208 cases of cervicocarcinoma and 84 related deaths and thus results to be cost-effective (16.130 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 217 cancer cases and 89 deaths could be prevented, with a very similar cost-effectiveness ratio. In Campania region, the net cost for woman vaccinated is 182 € for the single cohort and 186 € for the multiple cohort. |
| first_indexed | 2024-12-10T04:42:07Z |
| format | Article |
| id | doaj.art-994d4e6c4d964b43a8ee117c734e6c10 |
| institution | Directory Open Access Journal |
| issn | 2240-256X |
| language | English |
| last_indexed | 2024-12-10T04:42:07Z |
| publishDate | 2008-09-01 |
| publisher | SEEd Medical Publishers |
| record_format | Article |
| series | Farmeconomia: Health Economics and Therapeutic Pathways |
| spelling | doaj.art-994d4e6c4d964b43a8ee117c734e6c102022-12-22T02:01:51ZengSEEd Medical PublishersFarmeconomia: Health Economics and Therapeutic Pathways2240-256X2008-09-0191S717310.7175/fe.v9i1S.1014950CampaniaMaria Caterina Cavallo0Filippo Cipriani1Simone Gerzeli2Nadia Demarteau3Alessia Marocco4Francesco Bamfi5Università Bocconi, MilanoGlaxoSmithKline Spa, VeronaDipartimento di Statistica ed Economia Applicate L. Lenti, Università di PaviaGlaxoSmithKline Biologicals, Wavre (Belgio)GlaxoSmithKline Spa, VeronaGlaxoSmithKline Spa, VeronaIn Campania region 41,8% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 208 cases of cervicocarcinoma and 84 related deaths and thus results to be cost-effective (16.130 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 217 cancer cases and 89 deaths could be prevented, with a very similar cost-effectiveness ratio. In Campania region, the net cost for woman vaccinated is 182 € for the single cohort and 186 € for the multiple cohort.https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1014campaniahpv vaccinationeconomic & clinical impact |
| spellingShingle | Maria Caterina Cavallo Filippo Cipriani Simone Gerzeli Nadia Demarteau Alessia Marocco Francesco Bamfi Campania Farmeconomia: Health Economics and Therapeutic Pathways campania hpv vaccination economic & clinical impact |
| title | Campania |
| title_full | Campania |
| title_fullStr | Campania |
| title_full_unstemmed | Campania |
| title_short | Campania |
| title_sort | campania |
| topic | campania hpv vaccination economic & clinical impact |
| url | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1014 |
| work_keys_str_mv | AT mariacaterinacavallo campania AT filippocipriani campania AT simonegerzeli campania AT nadiademarteau campania AT alessiamarocco campania AT francescobamfi campania |